120 related articles for article (PubMed ID: 1433215)
1. (Pyridylcyanomethyl)piperazines as orally active PAF antagonists.
Carceller E; Almansa C; Merlos M; Giral M; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1992 Oct; 35(22):4118-34. PubMed ID: 1433215
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and platelet-activating factor (PAF)-antagonistic activities of 1,4-disubstituted piperazine derivatives.
Fukushi H; Mabuchi H; Itoh K; Terashita Z; Nishikawa K; Sugihara H
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):541-50. PubMed ID: 8004699
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl)cyanomethyl)piperazines as PAF antagonists.
Carceller E; Merlos M; Giral M; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1993 Oct; 36(20):2984-97. PubMed ID: 8411016
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and platelet-activating factor (PAF)-antagonistic activities of trisubstituted piperazine derivatives.
Fukushi H; Mabuchi H; Terashita Z; Nishikawa K; Sugihara H
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):551-9. PubMed ID: 8004700
[TBL] [Abstract][Full Text] [Related]
6. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
[TBL] [Abstract][Full Text] [Related]
7. 2-(3-Pyridyl)thiazolidine-4-carboxamides. 1. Novel orally active antagonists of platelet-activating factor (PAF).
Nagaoka H; Hara H; Suzuki T; Takahashi T; Takeuchi M; Matsuhisa A; Saito M; Yamada T; Tomioka K; Mase T
Chem Pharm Bull (Tokyo); 1997 Oct; 45(10):1659-64. PubMed ID: 9353894
[TBL] [Abstract][Full Text] [Related]
8. Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
Takatani M; Yoshioka Y; Tasaka A; Terashita Z; Imura Y; Nishikawa K; Tsushima S
J Med Chem; 1989 Jan; 32(1):56-64. PubMed ID: 2909744
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in platelet-activating factor. 12. Synthesis and biological evaluation of platelet-activating factor antagonists with anti-HIV-1 activity.
Serradji N; Martin M; Bensaid O; Cisternino S; Rousselle C; Dereuddre-Bosquet N; Huet J; Redeuilh C; Lamouri A; Dong CZ; Clayette P; Scherrmann JM; Dormont D; Heymans F
J Med Chem; 2004 Dec; 47(25):6410-9. PubMed ID: 15566310
[TBL] [Abstract][Full Text] [Related]
10. Effects of UR-12633, a new antagonist of platelet-activating factor, in rodent models of endotoxic shock.
Giral M; Balsa D; Ferrando R; Merlos M; Garcia-Rafanell J; Forn J
Br J Pharmacol; 1996 Jul; 118(5):1223-31. PubMed ID: 8818347
[TBL] [Abstract][Full Text] [Related]
11. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
[TBL] [Abstract][Full Text] [Related]
12. Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines.
Lamouri A; Heymans F; Tavet F; Dive G; Batt JP; Blavet N; Braquet P; Godfroid JJ
J Med Chem; 1993 Apr; 36(8):990-1000. PubMed ID: 8478911
[TBL] [Abstract][Full Text] [Related]
13. Discovery and preliminary pharmacology of Sch 37370, a dual antagonist of PAF and histamine.
Billah MM; Egan RW; Ganguly AK; Green MJ; Kreutner W; Piwinski JJ; Siegel MI; Villani FJ; Wong JK
Lipids; 1991 Dec; 26(12):1172-4. PubMed ID: 1819703
[TBL] [Abstract][Full Text] [Related]
14. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
Billah MM; Chapman RW; Egan RW; Gilchrest H; Piwinski JJ; Sherwood J; Siegel MI; West RE; Kreutner W
J Pharmacol Exp Ther; 1990 Mar; 252(3):1090-6. PubMed ID: 2319461
[TBL] [Abstract][Full Text] [Related]
15. PAF inhibitory activity of diketopiperazines: structure-activity relationships.
Shimazaki N; Shima I; Okamoto M; Yoshida K; Hemmi K; Hashimoto M
Lipids; 1991 Dec; 26(12):1175-8. PubMed ID: 1819704
[TBL] [Abstract][Full Text] [Related]
16. Biological effect of orally active platelet-activating factor receptor antagonist SM-10661.
Komuro Y; Imanishi N; Uchida M; Morooka S
Mol Pharmacol; 1990 Sep; 38(3):378-84. PubMed ID: 2402227
[TBL] [Abstract][Full Text] [Related]
17. Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine.
Kaminski JJ; Carruthers NI; Wong SC; Chan TM; Billah MM; Tozzi S; McPhail AT
Bioorg Med Chem; 1999 Jul; 7(7):1413-23. PubMed ID: 10465415
[TBL] [Abstract][Full Text] [Related]
18. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
[TBL] [Abstract][Full Text] [Related]
19. A novel class of platelet activating factor (PAF) antagonists. II. Modification of the 2-position of the glycerol backbone of PAF-sulfonamide isosteres.
Tsuri T; Matsui T; Haga N; Kamata S; Hagishita S; Takahashi K; Kakushi H; Uchida K; Hatakeyama H; Kurosawa A
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):85-95. PubMed ID: 1576692
[TBL] [Abstract][Full Text] [Related]
20. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo.
Terashita Z; Imura Y; Takatani M; Tsushima S; Nishikawa K
J Pharmacol Exp Ther; 1987 Jul; 242(1):263-8. PubMed ID: 3612533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
